Novo Nordisk Investigational Site

Chula Vista, California 91911

0 studies enrolling now · 14 studies all time

What they study most

Chronic Kidney Disease, Delivery Systems, Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, End-Stage Renal Disease

Studies at this site

• Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes — Completed
• A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events — Completed
• Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes — Completed
• The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis — Stopped early
• Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes — Completed
• Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes — Completed
• Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes — Completed
• Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir — Completed
• The Effect of NN1250 in Subjects With Type 2 Diabetes of Different Race and/or Ethnic Origin — Completed
• A Trial Investigating NN1218 in Subjects With Type 1 and Type 2 Diabetes — Completed
• Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes — Completed
• Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes — Completed
• Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes — Completed
• A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump — Completed